bifidobacterium bifidum | helicobacter pylori kx2 mgep | GeneSet Name |
-0.00015 | -0.04525 | MOOTHA_HUMAN_MITODB_6_2002 |
-0.00104 | -0.05512 | MOOTHA_MITOCHONDRIA |
-0.00015 | -0.02468 | REACTOME_ELECTRON_TRANSPORT_CHAIN |
-0.00001 | -0.02663 | MOOTHA_VOXPHOS |
-0.00023 | -0.01305 | SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP |
-0.00001 | -0.06632 | CORUM_RESPIRATORY_CHAIN_COMPLEX_I_HOLOENZYME_MITOCHONDRIAL |
-0.00072 | -0.06916 | ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_UP |
-0.00139 | -0.04124 | BORCZUK_MALIGNANT_MESOTHELIOMA_UP |
-0.00007 | -0.02204 | ALCALAY_AML_BY_NPM1_LOCALIZATION_DN |
-0.00190 | -0.06081 | CAFFAREL_RESPONSE_TO_THC_DN |
-0.00143 | -0.03996 | NCI_FOXM1PATHWAY |
-0.00003 | -0.00161 | SHEPARD_BMYB_TARGETS |
-0.00077 | -0.03239 | CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN |
-0.00022 | -0.04893 | TANG_SENESCENCE_TP53_TARGETS_DN |
-0.00053 | -0.06341 | LEE_LIVER_CANCER_SURVIVAL_DN |
-0.00264 | -0.05284 | WILCOX_PRESPONSE_TO_ROGESTERONE_UP |
-0.00051 | -0.03218 | LOPEZ_MESOTELIOMA_SURVIVAL_TIME_UP |
-0.00004 | -0.10206 | KEGG_CITRATE_CYCLE_TCA_CYCLE |
-0.15893 | -0.00028 | KEGG_FATTY_ACID_METABOLISM |
-0.07820 | -0.13670 | HASLINGER_B_CLL_WITH_17P13_DELETION |
-0.08432 | -0.11324 | NCI_CENTROSOME_MATURATION |
-0.00022 | -0.07595 | MONTERO_THYROID_CANCER_POOR_SURVIVAL_UP |
-0.02902 | -0.08113 | KUMAMOTO_RESPONSE_TO_NUTLIN_3A_DN |
-0.00153 | -0.18492 | CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_HD_MTX_DN |
-0.00119 | -0.08630 | WALLACE_JAK2_TARGETS_UP |
-0.16333 | -0.02118 | REACTOME_BRANCHED_CHAIN_AMINO_ACID_CATABOLISM |
-0.00726 | -0.02112 | THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN |
-0.00031 | -0.14035 | IVANOVA_HEMATOPOIESIS_INTERMEDIATE_PROGENITOR |
-0.02951 | -0.15550 | SANA_RESPONSE_TO_IFNG_DN |
-0.14622 | -0.19575 | TIEN_INTESTINE_PROBIOTICS_6HR_UP |
-0.04334 | -0.04721 | REACTOME_CENTROSOME_MATURATION |
-0.10805 | -0.04723 | REACTOME_PEROXISOMAL_LIPID_METABOLISM |
-0.00390 | -0.01359 | CORUM_F1F0-ATP_SYNTHASE_EC_3.6.3.14_MITOCHONDRIAL |
-0.08134 | -0.04522 | BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_48HR_DN |
-0.00930 | -0.10879 | WONG_MITOCHONDRIA_GENE_MODULE |
-0.07176 | -0.17913 | NCI_AURORA_A_PATHWAY |
-0.10731 | -0.10798 | YAGI_AML_WITH_T_8_21_TRANSLOCATION |
-0.00038 | -0.10197 | REACTOME_GLUCOSE_REGULATION_OF_INSULIN_SECRETION |
-0.00791 | -0.10610 | HONRADO_BREAST_CANCER_BRCA1_VS_BRCA2 |
-0.00227 | -0.04512 | PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_DN |
-0.06933 | -0.00656 | REACTOME_CHOLESTEROL_BIOSYNTHESIS |
-0.12803 | -0.05496 | REACTOME_LOSS_OF_NLP_FROM_MITOTIC_CENTROSOMES |
-0.01881 | -0.18790 | CORUM_GCN5-TRRAP_HISTONE_ACETYLTRANSFERASE_COMPLEX |
-0.00785 | -0.05369 | STARK_PREFRONTAL_CORTEX_22Q11_DELETION_DN |
-0.11825 | -0.09238 | IVANOVA_HEMATOPOIESIS_STEM_CELL_AND_PROGENITOR |
-0.00823 | -0.03129 | PENG_LEUCINE_DEPRIVATION_DN |
-0.00182 | -0.08936 | UDAYAKUMAR_MED1_TARGETS_UP |
-0.01496 | -0.06757 | HEIDENBLAD_AMPLICON_8Q24_UP |
-0.05731 | -0.17608 | PUIFFE_INVASION_INHIBITED_BY_ASCITES_UP |
-0.12038 | -0.08615 | DAZARD_UV_RESPONSE_CLUSTER_G5 |
-0.02318 | -0.06321 | REACTOME_APCDC20_MEDIATED_DEGRADATION_OF_CYCLIN_B |
-0.10160 | -0.03881 | ROSS_AML_WITH_AML1_ETO_FUSION |
-0.11777 | -0.01105 | SMITH_TERT_TARGETS_DN |
-0.18106 | -0.13997 | NCI_BETA_OXIDATION_OF_DECANOYL_COA_TO_OCTANOYL_COA_COA |
-0.02512 | -0.03318 | REACTOME_INFLUENZA_LIFE_CYCLE |
-0.00526 | -0.09845 | NCI_P38GAMMADELTAPATHWAY |
-0.06566 | -0.18287 | KEGG_COLORECTAL_CANCER |
-0.17256 | -0.02087 | KEGG_PEROXISOME |
-0.14855 | -0.05471 | REACTOME_FURTHER_PLATELET_RELEASATE |
-0.01617 | -0.00628 | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_13 |
-0.12068 | -0.11714 | FOURNIER_ACINAR_DEVELOPMENT_EARLY_UP |
-0.02481 | -0.05383 | REACTOME_INTEGRATION_OF_ENERGY_METABOLISM |
-0.05646 | -0.18269 | REACTOME_FORMATION_OF_TUBULIN_FOLDING_INTERMEDIATES_BY_CCT_TRIC |
-0.07164 | -0.00913 | REACTOME_DIABETES_PATHWAYS |
-0.13950 | -0.12983 | PYEON_HPV_POSITIVE_TUMORS_DN |
-0.09164 | -0.00048 | MOOTHA_FFA_OXYDATION |
-0.02064 | -0.00090 | CHEN_HOXA5_TARGETS_9HR_DN |
-0.01728 | -0.07869 | RAMASWAMY_METASTASIS_UP |
-0.03282 | -0.01038 | BOYLAN_MULTIPLE_MYELOMA_D_CLUSTER_DN |
-0.05676 | -0.13285 | NCI_RECRUITMENT_OF_MITOTIC_CENTROSOME_PROTEINS_AND_COMPLEXES |
-0.01366 | -0.03508 | REACTOME_REGULATION_OF_INSULIN_SECRETION |
-0.07811 | -0.05255 | WAMUNYOKOLI_OVARIAN_CANCER_LMP_UP |
-0.19540 | -0.16753 | NCI_CDC42_PATHWAY |
-0.07443 | -0.10240 | DOUGLAS_BMI1_TARGETS_UP |
-0.18165 | -0.08396 | LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_SMALL_VS_HUGE_UP |
-0.00146 | -0.03223 | LY_AGING_MIDDLE_DN |
-0.05291 | -0.07627 | KEGG_THYROID_CANCER |
-0.19680 | -0.00891 | KEGG_ALZHEIMERS_DISEASE |
-0.04372 | -0.06563 | NCI_APC_C_CDC20_MEDIATED_DEGRADATION_OF_CYCLIN_B |
-0.07686 | -0.05951 | REACTOME_GENES_INVOLVED_IN_APOPTOTIC_CLEAVAGE_OF_CELLULAR_PROTEINS |
-0.13191 | -0.08874 | BIOCARTA_AKAP95_PATHWAY |
-0.02067 | -0.10034 | NCI_INACTIVATION_OF_APC_C_VIA_DIRECT_INHIBITION_OF_THE_APC_C_COMPLEX |
-0.03076 | -0.02846 | NUYTTEN_NIPP1_TARGETS_DN |
-0.14916 | -0.15207 | CORUM_TGF-BETA_RECEPTOR_II-TGF-BETA_RECEPTOR_I-TGF-BETA3_COMPLEX |
-0.00718 | -0.07828 | MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_UP |
-0.14798 | -0.11575 | BROWNE_HCMV_INFECTION_16HR_DN |
-0.01014 | -0.01330 | CAIRO_HEPATOBLASTOMA_UP |
-0.02560 | -0.06448 | REACTOME_PHOSPHORYLATION_OF_THE_APC |
-0.14029 | -0.08425 | SCHLOSSER_SERUM_RESPONSE_AUGMENTED_BY_MYC |
-0.00153 | -0.12859 | GRADE_COLON_CANCER_UP |
-0.00373 | -0.00144 | DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN |
-0.10341 | -0.03987 | BAELDE_DIABETIC_NEPHROPATHY_UP |
-0.11834 | -0.16316 | KEGG_P53_SIGNALING_PATHWAY |
-0.00003 | -0.05496 | RHODES_UNDIFFERENTIATED_CANCER |
-0.05096 | -0.12498 | BHATTACHARYA_EMBRYONIC_STEM_CELL |
-0.11785 | -0.10598 | HUANG_DASATINIB_RESISTANCE_DN |
-0.03173 | -0.16617 | NCI_MITOTIC_TELOPHASE__CYTOKINESIS |
-0.02484 | -0.06727 | NCI_PHOSPHORYLATION_OF_THE_APC_C |
-0.00423 | -0.01868 | STEIN_ESRRA_TARGETS |
-0.06470 | -0.00309 | FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_DN |
-0.01923 | -0.12405 | LOPEZ_MBD_TARGETS |
-0.04166 | -0.07750 | NCI_APC_C_CDC20_MEDIATED_DEGRADATION_OF_MITOTIC_PROTEINS |
-0.08367 | -0.10588 | NCI_LOSS_OF_PROTEINS_REQUIRED_FOR_INTERPHASE_MICROTUBULE_ORGANIZATION_FROM_THE_CENTROSOME |
-0.00061 | -0.04505 | REACTOME_G2_M_TRANSITION |
-0.02669 | -0.04079 | SASAKI_ADULT_T_CELL_LEUKEMIA |
-0.07170 | -0.16967 | REACTOME_PREFOLDIN_MEDIATED_TRANSFER_OF_SUBSTRATE_TO_CCT_TRIC |
-0.11832 | -0.06310 | CORUM_CTCF-NUCLEOPHOSMIN-PARP-HIS-KPNA-LMNA-TOP_COMPLEX |
-0.06641 | -0.06271 | KEGG_BIOSYNTHESIS_OF_UNSATURATED_FATTY_ACIDS |
-0.00556 | -0.00605 | REACTOME_FORMATION_OF_ATP_BY_CHEMIOSMOTIC_COUPLING |
-0.10153 | -0.00166 | BIOCARTA_MPR_PATHWAY |
-0.10344 | -0.14211 | CORUM_SEMA6D-PLEXINA1-NRP1_COMPLEX |
-0.02271 | -0.09045 | REACTOME_INACTIVATION_OF_APC_VIA_DIRECT_INHIBITION_OF_THE_APCOMPLEX |
-0.00001 | -0.07933 | XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_DN |
-0.00019 | -0.18475 | SHEPARD_CRUSH_AND_BURN_MUTANT_DN |
-0.16297 | -0.08431 | CORUM_EMERIN_COMPLEX_25 |
-0.01075 | -0.00209 | KEGG_VALINE_LEUCINE_AND_ISOLEUCINE_DEGRADATION |
-0.00481 | -0.11512 | SESTO_RESPONSE_TO_UV_C6 |
-0.00006 | -0.11485 | JEON_SMAD6_TARGETS_DN |
-0.00144 | -0.16100 | PENG_GLUTAMINE_DEPRIVATION_DN |
-0.00001 | -0.12404 | SCIBETTA_KDM5B_TARGETS_DN |
-0.00352 | -0.08274 | REACTOME_TRANSFORMATION_OF_LANOSTEROL_TO_CHOLESTEROL |
-0.13123 | -0.06772 | NCI_FURTHER_PLATELET_RELEASATE |
-0.00242 | -0.06693 | NCI_REGULATION_OF_APC_C_ACTIVATORS_BETWEEN_G1_S_AND_EARLY_ANAPHASE |
-0.07237 | -0.15706 | APPIERTO_RESPONSE_TO_FENRETINIDE_DN |
-0.15911 | -0.05512 | FARMER_BREAST_CANCER_APOCRINE_VS_BASAL |
-0.00385 | -0.08620 | NCI_TRANSFORMATION_OF_LANOSTEROL_TO_CHOLESTEROL |
-0.11006 | -0.12397 | XU_RESPONSE_TO_TRETINOIN_DN |
-0.07288 | -0.07163 | BILD_E2F3_ONCOGENIC_SIGNATURE |
-0.05594 | -0.00021 | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_12 |
-0.01367 | -0.07556 | OHASHI_AURKB_TARGETS |
-0.10293 | -0.19233 | MILI_PSEUDOPODIA_HAPTOTAXIS_DN |
-0.07731 | -0.04673 | CORUM_RALBP1-CCNB1-AP2A-NUMB-EPN1_COMPLEX |
-0.00028 | -0.05125 | CORUM_RC_COMPLEX_DURING_G2/M-PHASE_OF_CELL_CYCLE |
-0.08186 | -0.06298 | BIOCARTA_HDAC_PATHWAY |
-0.00435 | -0.00274 | PRAMOONJAGO_SOX4_TARGETS_DN |
-0.01713 | -0.01552 | KEGG_PARKINSONS_DISEASE |
-0.12405 | -0.00968 | STEIN_ESRRA_TARGETS_DN |
-0.00440 | -0.10047 | SESTO_RESPONSE_TO_UV_C7 |
-0.00740 | -0.08702 | KEGG_HUNTINGTONS_DISEASE |
-0.05342 | -0.03505 | REACTOME_MITOCHONDRIAL_FATTY_ACID_BETA_OXIDATION |
-0.01217 | -0.00629 | MODY_HIPPOCAMPUS_PRENATAL |
-0.00459 | -0.01189 | KEGG_OOCYTE_MEIOSIS |
-0.17278 | -0.13483 | NCI_BETA_OXIDATION_OF_OCTANOYL_COA_TO_HEXANOYL_COA |
-0.01357 | -0.05605 | NCI_APC_CDC20_MEDIATED_DEGRADATION_OF_NEK2A |
-0.09374 | -0.07154 | KEGG_PROPANOATE_METABOLISM |
-0.08500 | -0.13410 | REACTOME_APOPTOTIC_EXECUTION_PHASE |
-0.06198 | -0.08492 | DAIRKEE_TERT_TARGETS_UP |
-0.07638 | -0.18262 | TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_UP |
-0.00248 | -0.02890 | STEIN_ESRRA_TARGETS_UP |
-0.02139 | -0.08659 | RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_UP |
-0.03158 | -0.04069 | CORUM_NOP56P-ASSOCIATED_PRE-RRNA_COMPLEX |
-0.06706 | -0.18462 | JAEGER_METASTASIS_UP |
-0.02061 | -0.07322 | POMEROY_MEDULLOBLASTOMA_PROGNOSIS_DN |
-0.08105 | -0.10130 | NCI_LOSS_OF_NLP_FROM_MITOTIC_CENTROSOMES |
-0.06913 | -0.14125 | LIAO_METASTASIS |
-0.09131 | -0.16063 | NCI_CONVERSION_FROM_APC_C_CDC20_TO_APC_C_CDH1_IN_LATE_ANAPHASE |
-0.00019 | -0.11953 | CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_DN |
-0.12742 | -0.19908 | ST_MYOCYTE_AD_PATHWAY |
-0.02551 | -0.13399 | BONOME_OVARIAN_CANCER_POOR_SURVIVAL_DN |
-0.12411 | -0.08393 | ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_DN |
-0.01698 | -0.16415 | TOMLINS_PROSTATE_CANCER_UP |
-0.17636 | -0.05947 | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_16 |
-0.15117 | -0.09820 | OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_UP |
-0.00693 | -0.00769 | NCI_FORMATION_OF_ATP_BY_CHEMIOSMOTIC_COUPLING |
-0.12174 | -0.13858 | NCI_ECADHERIN_STABILIZATION_PATHWAY |
-0.00016 | -0.19898 | NADERI_BREAST_CANCER_PROGNOSIS_UP |
-0.16481 | -0.01097 | REACTOME_SEMA3A_PAK_DEPENDENT_AXON_REPULSION |
-0.15048 | -0.15875 | CORUM_OLIGOSACCHARYLTRANSFERASE_COMPLEX_STT3B_VARIANT |
-0.00007 | -0.17471 | CORUM_RC_COMPLEX_DURING_S-PHASE_OF_CELL_CYCLE |
-0.02276 | -0.14118 | KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION |
-0.09986 | -0.09261 | KORKOLA_YOLK_SAC_TUMOR_UP |
-0.00138 | -0.13629 | LINDGREN_BLADDER_CANCER_CLUSTER_1_DN |